Familial Mediterranean Fever Clinical Trial
Official title:
Evaluation of Bone Metabolism in Children and Adolescents With Familial Mediterranean Fever and Correlation With Genotype
Familial Mediterranean Fever is a chronic auto-inflammatory disease. In the context of chronic inflammation, it seems that, among others, it also affects bone density in children. Bone loss may be due to subclinical inflammation that persists even during periods of remission. In addition, inflammatory cytokines also play an important role (mainly during episodes) resulting in an increase in bone degradation and ultimately a reduction in bone mass. Cytokines mainly associated with bone degradation and osteoclast activity are: IL-1R, IL-2, IL-6, IL-8, TNFa. The purpose of this study is to determine the effect of FMF on bone density and to compare the results with a healthy population. In addition, the difference between the children with FMF will be studied according to the mutation they carry.
For the above purpose, 62 children will participate, 31 healthy and 31 with FMF(confirmed mutation/s in the MEFV (Marenostrin Encoding Fever Gene) ). They will be separated based on gender (boys, girls) and age: 2 age groups: a) 6-12 years, b) 12 - 20 years, separation into pre-adolescent children and adolescents (according to Tanner) and Body Mass Index ( BMI) (3rd-90th ED). Of the 31 children with FMF, all will be treated with colchicine and the study will not take place during periods of disease attack. An attack free period is defined as a period of at least 3 weeks without clinical symptoms (fever, abdominal pain, arthritis) and without acute phase indicators (increased CRP, TKE, WBC). The healthy population will exclude children with a history of disease related to a bone disorder. In addition, the existence of other factors that could affect bone density will be investigated in all 62 children. For this reason, there will be a check of calcium metabolism, vitamin D, kidney function, hormonal check, thyroid function check. Biomarkers of the RANK/RANKL/OPG axis that have a major role in osteoblast/osteoclast activity will be tested. Children's physical activity will be also assessed. Bone density measurement will be done with a Hologic DISCOVERY QDR DXA (Dual Energy X-ray Absorptiometry) machine, the "gold standard" for spine and hip bone disorder screening worldwide. The program to be implemented will be adapted to childhood. Then the following will be assessed: Body Mineral Density (BMD), Body Mineral Content (BMC) and z-score for the vertebrae of the OMSS (O1-O4) and Total Body less Head (TBLH). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00658060 -
Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients
|
N/A | |
Withdrawn |
NCT05448391 -
A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)
|
Phase 2 | |
Recruiting |
NCT05190991 -
Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever
|
Phase 2 | |
Completed |
NCT00094900 -
Interleukin-1 Trap to Treat Autoinflammatory Diseases
|
Phase 2 | |
Not yet recruiting |
NCT06033339 -
Assessment of microRNAs Role in Familial Mediterranean Fever FMF Pathophysiology
|
N/A | |
Completed |
NCT01705756 -
Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
|
Phase 3 | |
Recruiting |
NCT06338891 -
Can Gluten/Wheat or Other Foods be Responsible for FMF Attacks
|
||
Recruiting |
NCT05596643 -
Investigation of Autonomic Dysfunction in Patients With Familial Mediterranean Fever
|
||
Enrolling by invitation |
NCT02175589 -
Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation
|
Phase 2 | |
Completed |
NCT05177120 -
Central Sensitization in Familial Mediterranean Fever (FMF)
|
||
Active, not recruiting |
NCT06257342 -
Physical Abilities of Teenagers With Familial Mediterranean Fever
|
||
Recruiting |
NCT04478409 -
Characterization of a Functional Test for Mediterranean Family Fever Screening - 2
|
||
Completed |
NCT04729218 -
The Movement Imagery Ability in Patients With Familial Mediterranean Fever
|
||
Terminated |
NCT01059279 -
Heat Intolerance in the Group of FMF Patients
|
||
Enrolling by invitation |
NCT04724993 -
Effects of Online Aerobic Exercise Training and Physical Activity Counseling in Juvenile Familial Mediterranean Fever
|
N/A | |
Completed |
NCT03747315 -
A Diagnostic Test for Familial Mediterranean Fever
|
||
Completed |
NCT01075906 -
Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients
|
Phase 1 | |
Withdrawn |
NCT00323440 -
Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
|
N/A | |
Completed |
NCT00582907 -
Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
|
Phase 2 | |
Not yet recruiting |
NCT05488561 -
Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their Siblings
|
N/A |